Back to Basics: Designing digital patient services

Elisa del Galdo|2nd July 2015


 

Head of Customer Experience Elisa del Galdo talks through the key considerations for pharma companies when designing and delivering digital patient services from a customer experience perspective.

As pharma marketing departments increasingly look towards digital services and solutions, there are a number of important considerations that companies cannot afford to neglect. Understanding client objectives should be the first port of call. When talking about innovation in marketing, the creation of digital services and multi-platform offerings often comes up. There has been a great deal of innovation applied to the provision of digital services and solutions within the pharmaceutical industry, in spite of the unique challenges created by strict regulations on the marketing of medical products. That said, the design and development of customer-focused services and solutions is a relatively new approach in this sector.

 

To read more, download the full PDF of this article, as it appeared in the IPT Online - Innovations in Pharmaceutical Technology June 2015 issue.  

Launch Excellence 2020

Blue Latitude Health|18th November 2019

In this publication, we explore what makes a successful pharma launch from developing insight that drives behaviour change to lean launches and multi-indication launches, as well as an evaluation of the CAR-T market.

read more

Precision medicine at Blue Latitude Health

Blue Latitude Health|7th November 2019

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.

read more

Understanding the evolving CAR-T market

Ditte Funding, Maria Katsarou, Natasha Cowan|1st November 2019

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?

read more